Two-level Adverse Events

Commonly Reported AEs Through Month 84 Mobi-C Fusion
Neck pain 41.0% 61.0%
Arm pain 25.6% 30.5%
Neck and arm pain 5.1% 7.6%
Back pain 36.8% 32.4%
Shoulder pain 29.1% 42.9%
Headache 27.4% 27.6%
Neurological - upper extremity sensory 42.7% 53.3%
Neurological - neck 20.5 21.0%
Dysphagia 17.1% 22.9%
Dysphonia 2.6% 1.9%
Surgical wound infection 3.4% 3.8%
Nonunion (ACDF only) - 14.3%
Heterotopic ossification rate at index levels (Mobi-C only) 8.5%     - 
Unanticipated adverse device effect 0.9% 3.8%

Note: Adverse event data includes the Mobi-C non-randomized training cases.

One-level Adverse Events

Commonly Reported AEs Through Month 84 Mobi-C Fusion
Neck pain 55.3% 54.3%
Arm pain 39.1% 30.9%
Neck and arm pain 5.6% 8.6%
Headache 33.5% 35.8%
Back pain 34.6% 33.3%
Neurological - neck 26.8% 29.6%
Neurological - upper extremity sensory 49.7% 51.9%
Shoulder pain 30.2% 28.4%
Dysphagia 12.3%  21.0%
Dysphonia 1.7% 4.9%
Surgical wound infection 3.4% 1.2%
Nonunion rate (fusion only) - 6.2%
Heterotopic ossification at index level (Mobi-C only) 6.1% -
Unanticipated adverse device effect 0.0% 0.0%